Cytokines associated with prolonged Cytopenia after axicabtagene ciloleucel in patients with refractory large B-cell lymphoma

被引：1

作者：

Strati, Paolo ^{[1
]}

Puebla-Osorio, Nahum ^{[1
]}

Han, Guangchun ^{[1
]}

Westin, Jason ^{[1
]}

Nastoupil, Loretta ^{[1
]}

Samaniego, Felipe ^{[1
]}

Fowler, Nathan ^{[1
]}

Fayad, Luis ^{[1
]}

Lee, Hun Ju ^{[1
]}

Flowers, Christopher ^{[1
]}

Srour, Samer ^{[1
]}

Watson, Grace ^{[1
]}

Wang, Linghua ^{[1
]}

Green, Michael ^{[1
]}

Neelapu, Sattva ^{[1
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-2049

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2049

引用

页数：2

共 50 条

[21] Clinical Efficacy of Polatuzumab Vedotin in Patients with Relapsed/Refractory Large B-Cell Lymphoma after Standard of Care Axicabtagene Ciloleucel
Strati, Paolo
Watson, Grace
Horowitz, Sandra B.
Nair, Ranjit
Rodriguez, Maria Alma
Steiner, Raphael Eric
Fayad, Luis
Westin, Jason R.
Neelapu, Sattva S.
BLOOD, 2020, 136
[22] Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
Shapiro, Lauren C.
Mustafa, Jennat
Lombardo, Amanda
Khatun, Fariha
Joseph, Felisha
Gillick, Kailyn
Naik, Anjali
Elkind, Richard
Abreu, Michelly
Fehn, Karen
de Castro, Alyssa
Pradhan, Kith
Binakaj, Donika
Nelson, Randin
Paroder, Monika
Uehlinger, Joan
Gritsman, Kira
Alejandro Sica, R.
Kornblum, Noah
Shastri, Aditi
Mantzaris, Ioannis
Bachier-Rodriguez, Lizamarie
Verma, Amit
Braunschweig, Ira
Goldfinger, Mendel
BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1761 - 1763
[23] Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma
Strati, Paolo
Tummala, Sudhakar
Nastoupil, Loretta J.
Westin, Jason R.
Fayad, Luis
Ahmed, Sairah
Fowler, Nathan H.
Hagemeister, F. B.
Lee, Hun Ju
Iyer, Swaminathan P.
Nair, Ranjit
Parmar, Simrit
Rodriguez, Maria Alma
Samaniego, Felipe
Steiner, Raphael Eric
Wang, Michael L.
Pinnix, Chelsea Camille
Adkins, Sherry
Claussen, Catherine M.
Martinez, Charles
Hawkins, Misha
Johnson, Nicole
George, Shirley
Neelapu, Sattva S.
Chi, Linda
BLOOD, 2019, 134
[24] Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma
Ionescu, Filip
Shah, Bijal D.
Menges, Meghan
Reid, Kayla
Bailey, Hanna
DiMaggio, Elizabeth
Gonzalez, Rebecca
Bachmeier, Christina A.
Corallo, Salvatore
Delgado, Luis Cuadrado
Mohammed, Turab
Nishihori, Taiga
Khimani, Farhad
Lazaryan, Aleksandr
Liu, Hien
Davila, Marco
Perna, Fabiana
Chavez, Julio C.
Locke, Frederick L.
Jain, Michael D.
BLOOD, 2023, 142
[25] Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
Lauren C. Shapiro
Jennat Mustafa
Amanda Lombardo
Fariha Khatun
Felisha Joseph
Kailyn Gillick
Anjali Naik
Richard Elkind
Michelly Abreu
Karen Fehn
Alyssa de Castro
Kith Pradhan
Donika Binakaj
Randin Nelson
Monika Paroder
Joan Uehlinger
Kira Gritsman
R. Alejandro Sica
Noah Kornblum
Aditi Shastri
Ioannis Mantzaris
Lizamarie Bachier-Rodriguez
Amit Verma
Ira Braunschweig
Mendel Goldfinger
Bone Marrow Transplantation, 2021, 56 : 1761 - 1763
[26] Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion
Gouni, Sushanth
Westin, Jason R.
Mistry, Haleigh
Steiner, Raphael Eric
James, Jinsu
Parmar, Simrit
Noorani, Mansoor
Fowler, Nathan H.
Horowitz, Sandra B.
Feng, Lei
Fayad, Luis E.
PIyer, Swaminathan
Green, Michael R.
Hawkins, Misha
Flowers, Christopher R.
Ahmed, Sairah
Nastoupil, Loretta
Neelapu, Sattva S.
Nieto, Yago
Strati, Paolo
BLOOD, 2021, 138
[27] Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Bharadwaj, Sushma
Lau, Eric
Hamilton, Mark P.
Goyal, Anmol
Srinagesh, Hrishi
Jensen, Alexandria
Lee, Dasom
Mallampet, Jayasindhu
Elkordy, Sarah
Syal, Shriya
Patil, Sunita
Latchford, Theresa
Sahaf, Bita
Arai, Sally
Johnston, Laura J.
Lowsky, Robert
Negrin, Robert
Rezvani, Andrew R.
Shizuru, Judith
Meyer, Everett H.
Shiraz, Parveen
Mikkilineni, Lekha
Weng, Wen-Kai
Smith, Melody
Sidana, Surbhi
Muffly, Lori
Maecker, Holden T.
Frank, Matthew J.
Mackall, Crystal
Miklos, David
Dahiya, Saurabh
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07)
[28] Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
Riedell, Peter A.
Bishop, Michael R.
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
[29] Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma
Strati, Paolo
Nastoupil, Loretta J.
Westin, Jason
Fayad, Luis E.
Ahmed, Sairah
Fowler, Nathan H.
Hagemeister, Fredrick B.
Lee, Hun J.
Iyer, Swaminathan P.
Nair, Ranjit
Parmar, Simrit
Rodriguez, Maria A.
Samaniego, Felipe
Steiner, Raphael E.
Wang, Michael
Pinnix, Chelsea C.
Adkins, Sherry
Claussen, Catherine M.
Martinez, Charles S.
Hawkins, Misha C.
Johnson, Nicole A.
Singh, Prachee
Mistry, Haleigh E.
Horowitz, Sandra
George, Shirley
Feng, Lei
Kebriaei, Partow
Shpall, Elizabeth J.
Neelapu, Sattva S.
Tummala, Sudhakar
Chi, T. Linda
BLOOD ADVANCES, 2020, 4 (16) : 3943 - 3951
[30] Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
Oluwole, Olalekan O.
Bouabdallah, Krimo
Munoz, Javier
De Guibert, Sophie
Vose, Julie M.
Bartlett, Nancy L.
Lin, Yi
Deol, Abhinav
McSweeney, Peter A.
Goy, Andre H.
Kersten, Marie Jose
Jacobson, Caron A.
Farooq, Umar
Minnema, Monique C.
Thieblemont, Catherine
Timmerman, John M.
Stiff, Patrick
Avivi, Irit
Tzachanis, Dimitrios
Kim, Jenny J.
Bashir, Zahid
McLeroy, Jeff
Zheng, Yan
Rossi, John M.
Johnson, Lisa
Goyal, Lovely
van Meerten, Tom
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (04) : 690 - 700

← 1 2 3 4 5 →